ClinicalTrials.Veeva

Menu

Thyroid Profiles in Patients With Acute Illness

J

Jordan Collaborating Cardiology Group

Status

Withdrawn

Conditions

Thyroid Dysfunction
Acute Illness

Treatments

Other: Performing blood thyroid test (TSH, FT4, FT3)

Study type

Observational

Funder types

Other

Identifiers

NCT05980923
DCR2023/1.ThyrAcuteIll

Details and patient eligibility

About

Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients.

Full description

Recently, there has been a growing body of evidence that subclinical thyroid dysfunction as a contributor to the increase of cardiovascular events. Elevated serum thyroid-stimulating hormone (TSH) levels and normal free thyroxine (FT4) and free triiodothyronine (FT3) levels have been associated with worse heart failure and dyslipidemia. Furthermore, higher risk of atrial fibrillation has been linked tp thyroid abnormalities in these patients.

Patients admitted to the hospital with acute illness may have a wide spectrum of thyroid function abnormalities. It is largely unknown whether such aberrations are temporary or persist for a long time, and whether they impact prognosis of such patients. This study aimed at evaluating the prevalence of thyroid function abnormalities in patients admitted to hospital with acute illness and their temporal changes and impact on mortality during hospitalization and at 1 year. Serum level of thyroid stimulating hormone and free T4 and T3 measured on admission. Clinical and laboratory profiles of patients with abnormal thyroid function (ATF group) will be compared to those with normal thyroid function (NTF group). Short and long term survival of both groups were compares as well.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospital admission
  • Adults aged 18 years and above
  • Willing to sign an informed consent
  • Diagnosis on admission is acute illness that includes: heart failure, acute coronary syndrome, sepsis, acute stroke, hypotension, acute system-organ failure including renal and hepatic failure.

Exclusion criteria

  • Age less than 18 years.
  • Refusal to sign consent.
  • Admission for a reason not classified as acute illness.

Trial design

0 participants in 2 patient groups

GROUP 1: Acute illness and abnormal thyroid function
Description:
Patients admitted to the hospital with acute illness and found to have thyroid function abnormalities.
Treatment:
Other: Performing blood thyroid test (TSH, FT4, FT3)
GROUP 2: Acute illness and normal thyroid function
Description:
Patients admitted to the hospital with acute illness and found to have normal thyroid function.
Treatment:
Other: Performing blood thyroid test (TSH, FT4, FT3)

Trial contacts and locations

1

Loading...

Central trial contact

Ayman J Hammoudeh, MD, FACC; Enas Younes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems